Redmile Group’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42M | Hold |
|
|||||
|
2025
Q1 | $22.1M | Hold |
|
|||||
|
2024
Q4 | $31.2M | Sell |
|
|||||
|
2024
Q3 | $49.4M | Buy |
|
|||||
|
2024
Q2 | $48.3M | Hold |
|
|||||
|
2024
Q1 | $68.6M | Sell |
|
|||||
|
2023
Q4 | $25.4M | Buy |
|
|||||
|
2023
Q3 | $12.7M | Buy |
|
|||||
|
2023
Q2 | $30.2M | Buy |
|
|||||
|
2023
Q1 | $26.5M | Buy |
|
|||||
|
2022
Q4 | $29.1M | Buy |
|
|||||
|
2022
Q3 | $36.2M | Hold |
|
|||||
|
2022
Q2 | $59.7M | Buy |
|
|||||
|
2022
Q1 | $109M | Sell |
|
|||||
|
2021
Q4 | $151M | Sell |
|
|||||
|
2021
Q3 | $204M | Buy |
|
|||||
|
2021
Q2 | $183M | Buy |
|
|||||
|
2021
Q1 | $178M | Buy |
|
|||||
|
2020
Q4 | $216M | Buy |
|
|||||
|
2020
Q3 | $210M | Buy |
|
|||||
|
2020
Q2 | $259M | Buy |
|